Edward Hopper - Compartment C Car |
I also have more kidney stones. Because today is my day, it seems.
So, at the recommendation of my oncologist, I'm moving on to a new drug combo and last month's Faslodex was my last Faslodex.
It was expected that this day would come, and I think I still did better than average, but I was hoping I'd get a longer run of it.
But, starting tonight, I'm on to Letrozole, an aromatase inhibitor. I'll be combining that with Ibrance, the new drug from Pfizer that was just approved by the FDA 2 months ago. Timing is everything.
The Ibrance will take a few weeks to get (it has to come through the mail from a speciality pharmacy) and my oncologist wants me to wait until after I get back from the first away vacation I've taken in years later this month--it should be fine, but it seems a little ironic that I had 12 mostly uneventful months on Faslodex and the one week in 3 years that I plan to get on a plane for fun, and this happens. As I said, timing is everything.
Letrozole's side effects should be similar to Faslodex. Ibrance brings fatigue and low blood cell counts (red and white), so that may be a little more of a challenge. Or maybe not.
The good news is, in the clinical trials, the Ibrance/Letrozole combo had a median progression free survival of 20 months, which compares to 10 months with Letrozole alone. Those were women who had not already failed a different hormone drug like I did on Faslodex, so it may not be as good for me, but obviously median PFS is a guideline not a promise, anyway.
I guess I'm getting better at cancer these days. I'm sad, but for now I'm feeling like it's ok. It's time to roll up my sleeves again and move on to this next treatment. And fortunately I'm not out of treatments yet.
And so I move on. And hope this next new thing will be the next new thing. And so it goes.
No comments:
Post a Comment